Related Experiment Video

Updated: Jun 6, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Structural dynamics of kappa opioid receptor interactions with β-arrestin 1

Jianming Han1, Eve J Fine2,3,4,5,6, Qianru Jiang7

  • 1Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA. jianming@wustl.edu.

Nature Communications
|June 4, 2026
PubMed

Insights

Researchers elucidated the kappa opioid receptor (KOR)-β-arrestin1 (βarr1) complex structure, revealing key interactions and dynamics. This provides insights into opioid signaling pathways and potential therapeutic targets.

Area of Science:

  • Structural biology
  • Neuroscience
  • Pharmacology

Background:

  • Opioid receptors mediate diverse drug effects via Gi/o protein and β-arrestin pathways.
  • While G protein signaling is understood, β-arrestin recruitment mechanisms remain unclear.

Purpose of the Study:

  • To determine the structural basis of β-arrestin recruitment to the kappa opioid receptor (KOR).
  • To investigate factors influencing KOR-β-arrestin interactions and signaling bias.

Main Methods:

  • Cryogenic electron microscopy (cryo-EM) to resolve the KOR-β-arrestin1 complex structure at 2.60 Å resolution.
  • Mass spectrometry for identifying phosphorylation sites and phospholipid-binding interactions.
  • 3D variation analysis and molecular dynamics simulations for conformational dynamics.

Main Results:

  • The KOR-β-arrestin1 complex structure reveals specific interaction interfaces and unique features compared to other GPCR-β-arrestin complexes.
  • Phosphorylation sites and a phospholipid-binding site were identified, enhancing β-arrestin recruitment.
  • Distinct structural characteristics in the KOR binding site and transducer interface influence signaling bias.
  • Conformational dynamics suggest an allosteric pathway for β-arrestin binding and dissociation.

Conclusions:

  • The study provides the first high-resolution structure of the KOR-β-arrestin1 complex, elucidating molecular interactions.
  • Findings reveal novel mechanisms of β-arrestin recruitment and regulation, including allosteric modulation.
  • Structural insights into signaling bias offer potential for developing biased opioid agonists with improved therapeutic profiles.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...